ReviewCurrent treatment options in oncology2015

Integrating bone targeting radiopharmaceuticals into the management of patients with castrate-resistant prostate cancer with symptomatic bone metastases.

Seth R Blacksburg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.